SCHEMBL7447227

SCHEMBL7447227

N=C(N)N1CCC(CC(=O)N2CCN(C(=O)O[C@H]3CCC[C@@H](OC(=O)N4CCN(C(=O)CC5CCN(C(=N)N)CC5)CC4)CCC3)CC2)CC1.O=C(O)N1CCN(C(=O)CCCC2CCNCC2)CC1

nearest known ligand 0.70

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TPSAB1 Q15661 17/20 0.70
TPSD1 Q9BZJ3 17/20 0.70
TPSG1 Q9NRR2 17/20 0.70
PRSS1 P07477 10/20 0.62
PRSS2 P07478 7/20 0.62
PRSS3 P35030 7/20 0.62
F2 P00734 6/20 0.62
ITGB3 P05106 2/20 0.47
ITGA2B P08514 2/20 0.47
GNAI3 P08754 1/20 0.44
GNAO1 P09471 1/20 0.44
GNAI1 P63096 1/20 0.44
PLG P00747 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7447251 0.87 TPSAB1 (0.73) TPSAB1TPSD1TPSG1PRSS1PRSS2
SCHEMBL7446733 0.83 TPSAB1 (1.00) TPSAB1TPSD1TPSG1PRSS1PRSS2
SCHEMBL7958531 0.82 TPSAB1 (1.00) TPSAB1TPSD1TPSG1PRSS1PRSS2
SCHEMBL7441982 0.81 TPSAB1 (0.77) TPSAB1TPSD1TPSG1PRSS1PRSS2
SCHEMBL7551894 0.81 TPSAB1 (0.94) TPSAB1TPSD1TPSG1PRSS1PRSS2
SCHEMBL7420671 0.80 TPSAB1 (1.00) TPSAB1TPSD1TPSG1PRSS1PRSS2
SCHEMBL7550052 0.79 TPSAB1 (0.65) TPSAB1TPSD1TPSG1PRSS1PRSS2
SCHEMBL7503864 0.77 TPSAB1 (0.71) TPSAB1TPSD1TPSG1PRSS1PRSS2
SCHEMBL7446613 0.77 TPSAB1 (0.94) TPSAB1TPSD1TPSG1PRSS1PRSS2
SCHEMBL7447693 0.76 TPSAB1 (0.78) TPSAB1TPSD1TPSG1PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934293-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH TRYPTASE ACTIVITY ARRIS PHARMACEUTICAL CORPORATION (US) 1999-08-11 EP disclosed
WO-1998004537-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH TRYPTASE ACTIVITY ARRIS PHARMACEUTICAL CORPORATION (US) 1998-02-05 WO disclosed